Terms: = Brain cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
1270 results:
1. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
[TBL] [Abstract] [Full Text] [Related]
2. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
3. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
4. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
5. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
6. Dual path parallel hierarchical diagnosis model for intracranial tumors based on multi-feature entropy weight.
Fang L; Jiang Y
Comput Biol Med; 2024 May; 173():108353. PubMed ID: 38520918
[TBL] [Abstract] [Full Text] [Related]
7. Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients.
Zhang T; Zhang Q; He X; Lu Y; Shao A; Sun X; Shao Y
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474320
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Lofiego MF; Piazzini F; Caruso FP; Marzani F; Solmonese L; Bello E; Celesti F; Costa MC; Noviello T; Mortarini R; Anichini A; Ceccarelli M; Coral S; Di Giacomo AM; Maio M; Covre A;
J Transl Med; 2024 Mar; 22(1):223. PubMed ID: 38429759
[TBL] [Abstract] [Full Text] [Related]
9. Strategy for Identifying a Robust Metabolomic Signature Reveals the Altered Lipid Metabolism in Pituitary Adenoma.
Tang J; Mou M; Zheng X; Yan J; Pan Z; Zhang J; Li B; Yang Q; Wang Y; Zhang Y; Gao J; Li S; Yang H; Zhu F
Anal Chem; 2024 Mar; 96(12):4745-4755. PubMed ID: 38417094
[TBL] [Abstract] [Full Text] [Related]
10. Functional Selection of Tau Oligomerization-Inhibiting Aptamers.
Wang B; Pan X; Teng IT; Li X; Kobeissy F; Wu ZY; Zhu J; Cai G; Yan H; Yan X; Liang M; Yu F; Lu J; Yang Z; Biondi E; Haskins W; Cao YC; Benner SA; Tan W; Wang KK
Angew Chem Int Ed Engl; 2024 Apr; 63(18):e202402007. PubMed ID: 38407551
[TBL] [Abstract] [Full Text] [Related]
11. NeuroIGN: Explainable Multimodal Image-Guided System for Precise brain Tumor Surgery.
Zeineldin RA; Karar ME; Burgert O; Mathis-Ullrich F
J Med Syst; 2024 Feb; 48(1):25. PubMed ID: 38393660
[TBL] [Abstract] [Full Text] [Related]
12. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
13. Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
Štrublová L; Kepák T; Kuruczová D; Zlámal F; Holíková M; Kepáková K; Štěrba J; Bienertová-Vašků J
PLoS One; 2024; 19(2):e0298068. PubMed ID: 38363727
[TBL] [Abstract] [Full Text] [Related]
14. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
[TBL] [Abstract] [Full Text] [Related]
15. Developing a comparative photon-proton planning service in Victoria: the experience at Peter MacCallum cancer Centre.
Gunewardena R; Hall L; Li M; Drum G; Le D; Nigro E; Houlder B; Phillips C; Wheeler G; Wiltshire K; Kron T; Yeo A
J Med Radiat Sci; 2024 Apr; 71 Suppl 2(Suppl 2):82-89. PubMed ID: 38305062
[TBL] [Abstract] [Full Text] [Related]
16. An MRI brain tumor segmentation method based on improved U-Net.
Zhu J; Zhang R; Zhang H
Math Biosci Eng; 2024 Jan; 21(1):778-791. PubMed ID: 38303443
[TBL] [Abstract] [Full Text] [Related]
17. Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.
Gritsch D; Santagata S; Brastianos PK
Curr Treat Options Oncol; 2024 Feb; 25(2):261-273. PubMed ID: 38300480
[TBL] [Abstract] [Full Text] [Related]
18. KLF8 Promotes the Survival of Lung Adenocarcinoma During Nutrient Deprivation by Regulating the Pentose Phosphate Pathway through SIRT2.
Bai Q; Jin W; Chen F; Zhu J; Cao L; Yang Y; Zhong F; Li L
Front Biosci (Landmark Ed); 2024 Jan; 29(1):27. PubMed ID: 38287804
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion.
Yu W; Zhou M; Niu H; Li J; Li Q; Xu X; Liang F; Rui C
BMC Cancer; 2024 Jan; 24(1):140. PubMed ID: 38287266
[TBL] [Abstract] [Full Text] [Related]
20. PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
Heuer S; Burghaus I; Gose M; Kessler T; Sahm F; Vollmuth P; Venkataramani V; Hoffmann D; Schlesner M; Ratliff M; Hopf C; Herrlinger U; Ricklefs F; Bendszus M; Krieg SM; Wick A; Wick W; Winkler F
BMC Cancer; 2024 Jan; 24(1):135. PubMed ID: 38279087
[TBL] [Abstract] [Full Text] [Related]
[Next]
